SGAustria looks forward to full commercialization of Cell-in-a-Box® driven by changes in PharmaCyte Board of Directors

… Biotech, Inc. (NASDAQ:PMCB) SINGAPORE, October 10, 2022 … not unusual for these novel, and highly complex cell … footprint and operations in Singapore and Thailand. SGAustria performs … develops and manufactures a novel and proprietary technology for …